The nation's private employers hired 191,000 workers in March to lift the markets to a higher open with the Dow gaining 20 points to 16,552. Nasdaq added 7 points to 4275.
On the upside
A Food and Drug Administration advisory panel recommended approval for MannKind's (Nasdaq: MNKD) inhalable insulin product AFREZZA.
The Centers for Medicare & Medicaid Services increased the reimbursement amount for BRCA1 and BRCA2 sequencing sending shares of Myriad Genetics (Nasdaq: MYGN) soaring.
On the downside
Apollo Education Group (Nasdaq: APOL) reported higher second quarter earnings but revenue fell short of analyst expectations.
Robert W. Baird said that Liquidity Services' (Nasdaq: LQDT) winning bid for a Defense Logistics Agency contract was too high.
Investors locked in profits on Higherpower International (Nasdaq: HPJ).
In the broad market, advancing issues were on par with decliners on both the NYSE and on Nasdaq. The broader S&P 500 added 3 points to 1888. Bitcoin fell $21.83 or 4.49% to $464.94.